Synonyms: Avelox® | BAY-12-8039 | BAY-128039 | BAY128039 | MFX | MOXIVIG® (opthalmic solution)
moxifloxacin is an approved drug (FDA (1999), UK (2009))
Compound class:
Synthetic organic
Comment: Moxifloxacin is a fourth generation fluoroquinolone antibacterial. Compared to earlier generation fluoroquinolones it has expanded activity against Gram-positive bacteria and some atypical pathogens.
|
|
Bioactivity Comments |
MIC90 for antibacterial activity against ciprofloxacin and methicillin resistant Staphylococcus aureus is 4 μg/ml in vitro [2]. |
Targets where the ligand is described in the comment field | |
Target | Comment |
DNA gyrase |
DNA gyrase is a type II DNA topoisomerase [1] and one of two enzymes of this subclass found in bacteria, the other being DNA topoisomerase 4. DNA gyrase introduces negative supercoils in closed circular double-stranded DNA in an ATP-dependent manner. This enzyme is the clinically-validated target for a number of antibacterial drug classes, including the aminocoumarins such as novobiocin and fluoroquinolones such as moxifloxacin, levofloxacin, ciprofloxacin and ofloxacin. |